Prostate Cancer and Prostatic Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Global burden and temporal trends of lower urinary tract symptoms: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 21 November 2022; doi:10.1038/s41391-022-00610-wGlobal burden and temporal trends of lower urinary tract symptoms: a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 21, 2022 Category: Urology & Nephrology Authors: Junjie Huang Chi-Kwok Chan Samuel Yee Yunyang Deng Yijun Bai Sze Chai Chan Man Sing Tin Xianjing Liu Veeleah Lok Lin Zhang Wanghong Xu Zhi-Jie Zheng Jeremy Yuen-Chun Teoh Chi-Fai Ng Martin C. S. Wong Source Type: research

Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 21 November 2022; doi:10.1038/s41391-022-00615-5Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 21, 2022 Category: Urology & Nephrology Authors: Giuseppe Bronte Vincenza Conteduca Matteo Landriscina Antonio Domenico Procopio Source Type: research

Robotic assisted simple prostatectomy versus other treatment modalities for large benign prostatic hyperplasia: a systematic review and meta-analysis of over 6500 cases
Prostate Cancer and Prostatic Diseases, Published online: 19 November 2022; doi:10.1038/s41391-022-00616-4Robotic assisted simple prostatectomy versus other treatment modalities for large benign prostatic hyperplasia: a systematic review and meta-analysis of over 6500 cases (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 19, 2022 Category: Urology & Nephrology Authors: Savio Domenico Pandolfo Francesco Del Giudice Benjamin I. Chung Celeste Manfredi Marco De Sio Rocco Damiano Edward E. Cherullo Cosimo De Nunzio Giovanni E. Cacciamani Luca Cindolo Francesco Porpiglia Vincenzo Mirone Ciro Imbimbo Riccardo Autorino Fabio Cr Source Type: research

Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations
Prostate Cancer and Prostatic Diseases, Published online: 19 November 2022; doi:10.1038/s41391-022-00612-8Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 19, 2022 Category: Urology & Nephrology Authors: Corbin J. Eule Thomas W. Flaig Katy Wong Ryon Graf Elaine T. Lam Source Type: research

Genetic profiling of hormone-sensitive and castration-resistant prostate cancers and identification of genetic mutations prone to castration-resistant prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 18 November 2022; doi:10.1038/s41391-022-00618-2Genetic profiling of hormone-sensitive and castration-resistant prostate cancers and identification of genetic mutations prone to castration-resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 18, 2022 Category: Urology & Nephrology Authors: Ze Wang Xuzhi Yan Peng Tang Tang Tang Yapeng Wang Song Peng Shuo Wang Weihua Lan Luofu Wang Yao Zhang Jun Zhang Ke Li Zehua Shu Jing Xu Jun Qin Dianzheng Zhang Jun Jiang Qiuli Liu Source Type: research

Racial disparities in treatment patterns for localized prostate cancer in an equal access system: What are we missing?
Prostate Cancer and Prostatic Diseases, Published online: 15 November 2022; doi:10.1038/s41391-022-00614-6Racial disparities in treatment patterns for localized prostate cancer in an equal access system: What are we missing? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 15, 2022 Category: Urology & Nephrology Authors: Fabio Crocerossa M. Carmen Mir Source Type: research

The effect of race on treatment patterns and subsequent health-related quality of life outcomes in men undergoing treatment for localized prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 10 November 2022; doi:10.1038/s41391-022-00608-4The effect of race on treatment patterns and subsequent health-related quality of life outcomes in men undergoing treatment for localized prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 10, 2022 Category: Urology & Nephrology Authors: Natasza M. Posielski Santosh Shanmuga On Ho Jiji Jiang Sally Elsamanoudi Ryan Speir Sean Stroup John Musser Alexander Ernest Gregory T. Chesnut Timothy Tausch John Paul Flores Christopher Porter Source Type: research

Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 25 October 2022; doi:10.1038/s41391-022-00607-5Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 25, 2022 Category: Urology & Nephrology Authors: Pawel Rajwa Takafumi Yanagisawa Isabel Heidegger Fabio Zattoni Giancarlo Marra Timo F. W. Soeterik Roderick C. N. van den Bergh Massimo Valerio Francesco Ceci Claudia V. Kesch Veeru Kasivisvanathan Ekaterina Laukhtina Tatsushi Kawada Peter Nyiriadi Quoc-D Source Type: research

Plant-based diets to reduce prostate cancer risk and improve prostate cancer outcomes—ready for prime time?
Prostate Cancer and Prostatic Diseases, Published online: 19 October 2022; doi:10.1038/s41391-022-00601-xPlant-based diets to reduce prostate cancer risk and improve prostate cancer outcomes—ready for prime time? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 19, 2022 Category: Urology & Nephrology Authors: Nadine A. Friedrich Stephen J. Freedland Ilona Csizmadi Source Type: research

Incidence and survival of castration-resistant prostate cancer patients with visceral metastases: results from the Dutch CAPRI-registry
Prostate Cancer and Prostatic Diseases, Published online: 12 October 2022; doi:10.1038/s41391-022-00605-7Incidence and survival of castration-resistant prostate cancer patients with visceral metastases: results from the Dutch CAPRI-registry (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 12, 2022 Category: Urology & Nephrology Authors: Gijs P. A. van den Bergh Malou C. P. Kuppen Hans M. Westgeest Niven Mehra Winald R. Gerritsen Katja K. H. Aben Inge M. van Oort Reindert J. A. van Moorselaar Diederik M. Somford Alfonsus J. M. van den Eertwegh Andr é M. Bergman Alphonsus C. M. van den Be Source Type: research

“Targeted microwave ablation: another way to kick the can(cer) down the road?”
Prostate Cancer and Prostatic Diseases, Published online: 11 October 2022; doi:10.1038/s41391-022-00603-9“Targeted microwave ablation: another way to kick the can(cer) down the road?” (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 11, 2022 Category: Urology & Nephrology Authors: Ting Martin Ma Amar U. Kishan Source Type: research

Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 10 October 2022; doi:10.1038/s41391-022-00600-yOncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 10, 2022 Category: Urology & Nephrology Authors: Giorgio Ivan Russo Timo Soeterik Ignacio Puche-Sanz Giuseppe Broggi Arturo Lo Giudice Cosimo De Nunzio Riccardo Lombardo Giancarlo Marra Giorgio Gandaglia Source Type: research

Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
Prostate Cancer and Prostatic Diseases, Published online: 10 October 2022; doi:10.1038/s41391-022-00596-5Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 10, 2022 Category: Urology & Nephrology Authors: Yu-Hsuan Joni Shao Jian-Hua Hong Chun-Kai Chen Chao-Yuan Huang Source Type: research

Urinary microbiota and prostatic diseases: the key for the lock? A systematic review
Prostate Cancer and Prostatic Diseases, Published online: 08 October 2022; doi:10.1038/s41391-022-00602-wUrinary microbiota and prostatic diseases: the key for the lock? A systematic review (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 8, 2022 Category: Urology & Nephrology Authors: Georges Mjaess Aya Karam Thierry Roumegu ère Romain Diamand Fouad Aoun Kevin McVary Judd W. Moul Cosimo De Nunzio Simone Albisinni Source Type: research

MRI-targeted biopsy cores from prostate index lesions: assessment and prediction of the number needed
Prostate Cancer and Prostatic Diseases, Published online: 08 October 2022; doi:10.1038/s41391-022-00599-2MRI-targeted biopsy cores from prostate index lesions: assessment and prediction of the number needed (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 8, 2022 Category: Urology & Nephrology Authors: Nick Lasse Beetz Franziska Dr äger Charlie Alexander Hamm Seyd Shnayien Madhuri Monique Rudolph Konrad Frob öse Sefer Elezkurtaj Matthias Haas Patrick Asbach Bernd Hamm Samy Mahjoub Frank Konietschke Maximilian Wechsung Felix Balzer Hannes Cash Sebastia Source Type: research